Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery

References

• Siegel RL, Miller KD, Jemal A. (2015). Cancer statistics, 2015. CA Cancer J Clin 65:5–29.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. American Association for the Study of Liver Diseases. (2011). Management of hepatocellular carcinoma: an update. Hepatology 53:1020–2.
   PubMed Web of Science ®Google Scholar
• Poon RT, Fan ST, Lo CM, et al. (2000). Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 18:1094–101.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. Global Health and Aging. Available from: http://www.nia.nih.gov/research/publication/global-health-and-aging/preface [last accessed 1 Jul 2015].
   Google Scholar
• El-Serag HB. (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264–73.
   PubMed Web of Science ®Google Scholar
• Camma C, Di Marco V, Orlando A, et al. (2005). Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 42:535–40.
   PubMed Web of Science ®Google Scholar
• Poon RTP, Fan ST, Tsang FHF, Wong J. (2002). Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 235:466–86.
   PubMed Web of Science ®Google Scholar
• Tateishi R, Shiina S, Teratani T, et al. (2005). Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–9.
   PubMed Web of Science ®Google Scholar
• Song KD, Lim HK, Rhim H, et al. (2015). Repeated hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma after hepatic resection: a propensity score matching study. Radiology 275:599–608.
   PubMed Web of Science ®Google Scholar
• Huang GL, Lin MX, Xie XY, et al. (2014). Combined radiofrequency ablation and ethanol injection with amultipronged needle for the treatment of medium and large hepatocellular carcinoma. Eur Radiol 24:1565–71.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Liang HH, Chen MS, et al. (2007). Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 244:599–607.
   PubMed Web of Science ®Google Scholar
• Vallone P, Catalano O, Izzo F, Siani A. (2006). Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Cardiovasc Intervent Radiol 29:544–51.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, Llovet JM, et al. (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–30.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. (2005). Management of hepatocellular carcinoma. Hepatology 42:1208–36.
   PubMed Web of Science ®Google Scholar
• Strasberg SM. (2005). Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 12:351–5.
   PubMedGoogle Scholar
• Ahmed M, Solbiati L, Brace CL, et al. (2014). Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. Radiology 273:241–60.
   PubMed Web of Science ®Google Scholar
• Peng ZW, Zhang YJ, Chen MS, et al. (2013). Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 31:426–32.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Wittekind C. (2002). TNM classification of malignant tumours. 6th ed. Hoboken, NJ: John Wiley & Sons.
   Google Scholar
• Monfardini L, Della Vigna P, Bonomo G, et al. (2013). Interventional oncology in the elderly: complications and early response in liver and kidney malignancies. J Geriatr Oncol 4:58–63.
   PubMed Web of Science ®Google Scholar
• Mak PH, Campbell RC, Irwin MG. American Society of Anesthesiologists. (2002). The ASA physical status classification: inter-observer consistency. Anaesth Intensive Care 30:633–40.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute: Common Toxicity Criteria, Version 4.0: Cancer Therapy Evaluation Program, 2009. Available from: http://evs.nci.Nih.Gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_Quick-Reference_5x7.pdf.
   Google Scholar
• Omary RA, Bettmann MA, Cardella JF, et al. (2003). Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 14:S293–5.
   PubMed Web of Science ®Google Scholar
• Søreide K, Wijnhoven BP. (2016). Surgery for an ageing population. Br J Surg 103:e7–9.
   PubMed Web of Science ®Google Scholar
• Tsujita E, Utsunomiya T, Ohta M, et al. (2010). Outcome of repeat hepatectomy in patients with hepatocellular carcinoma aged 75 years and older. Surgery 147:696–703.
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Sposito C, Pinna AD, et al. (2016). Effect of age on survival in patients undergoing resection of hepatocellular carcinoma. Br J Surg 103:e93–9.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zhu J, et al. (2016). Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387:251–72.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Kruskal JB, Oliver BS, et al. (2000). Percutaneous tumor ablation: increased coagulation by combining radio-frequency ablation and ethanol instillation in a rat breast tumor model. Radiology 217:827–31.
   PubMed Web of Science ®Google Scholar
• Wong SN, Lin CJ, Lin CC, et al. (2008). Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. Am J Roentgenol 190:W187–95.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Kokudo N, Makuuchi M, et al. (2013). Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 58:724–9.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lim HK, Rhim H, et al. (2013). Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97.
   PubMed Web of Science ®Google Scholar
• Feng K, Yan J, Li X, et al. (2012). A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802.
   PubMed Web of Science ®Google Scholar
• Zerbini A, Pilli M, Fagnoni F, et al. (2008). Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation. J Immunother 31:271–82.
   PubMed Web of Science ®Google Scholar
• Itamoto T, Nakahara H, Amano H, et al. (2007). Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141:589–97.
   PubMed Web of Science ®Google Scholar
• Wu CC, Cheng SB, Yeh DC, et al. (2009). Second and third hepatectomies for recurrent hepatocellular carcinoma are justified. Br J Surg 96:1049–57.
   PubMed Web of Science ®Google Scholar
• Huang ZY, Liang BY, Xiong M, et al. (2012). Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol 19:2515–25.
   PubMed Web of Science ®Google Scholar
• Kuang M, Lu MD, Xie XY, et al. (2007). Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna – experimental and clinical studies. Radiology 242:914–24.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zheng Y, Li S, et al. (2013). Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol 68:21–6.
   PubMed Web of Science ®Google Scholar
• Abdelaziz A, Elbaz T, Shousha HI, et al. (2014). Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience. Surg Endosc 28:3429–34.
   PubMed Web of Science ®Google Scholar
• Cornelis FH, Durack JC, Kimm SY, et al. (2017). A Comparative study of ablation boundary sharpness after percutaneous radiofrequency, cryo-, microwave, and irreversible electroporation ablation in normal swine liver and kidneys. Cardiovasc Intervent Radiol. [Epub ahead of print]. DOI: 10.1007/s00270-017-1692-3.
   Web of Science ®Google Scholar